Shigemitsu Ueyama

575 total citations
15 papers, 446 citations indexed

About

Shigemitsu Ueyama is a scholar working on Clinical Biochemistry, Molecular Biology and Cell Biology. According to data from OpenAlex, Shigemitsu Ueyama has authored 15 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Biochemistry, 5 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Shigemitsu Ueyama's work include Advanced Glycation End Products research (7 papers), Redox biology and oxidative stress (4 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Shigemitsu Ueyama is often cited by papers focused on Advanced Glycation End Products research (7 papers), Redox biology and oxidative stress (4 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Shigemitsu Ueyama collaborates with scholars based in Japan and India. Shigemitsu Ueyama's co-authors include Satoshi Miyata, Masato Kasuga, Yasuhiro Hamada, Hiroyuki Miyazaki, Yushi Hirota, Osamu Muramoto, Bing-Fen Liu, Keiji Nakasho, Takashi Fujisawa and Takashi Nishigami and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Annals of the New York Academy of Sciences and Kidney International.

In The Last Decade

Shigemitsu Ueyama

15 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigemitsu Ueyama Japan 10 207 125 85 58 56 15 446
Amir Ghorbani Haghjo Iran 12 152 0.7× 157 1.3× 51 0.6× 151 2.6× 49 0.9× 17 532
Beatriz Paradela‐Dobarro Spain 12 153 0.7× 80 0.6× 47 0.6× 124 2.1× 27 0.5× 20 381
Phyllis Chew Australia 8 97 0.5× 165 1.3× 161 1.9× 46 0.8× 18 0.3× 9 541
Zechun Kang China 10 67 0.3× 191 1.5× 50 0.6× 30 0.5× 33 0.6× 12 453
Somayeh Aslani Iran 7 128 0.6× 116 0.9× 34 0.4× 85 1.5× 28 0.5× 15 360
Clara Araújo Veloso Brazil 10 131 0.6× 95 0.8× 58 0.7× 73 1.3× 15 0.3× 16 387
Yoshitada Yajima Japan 12 66 0.3× 97 0.8× 74 0.9× 239 4.1× 26 0.5× 28 504
Yicheng Jiang China 7 88 0.4× 129 1.0× 51 0.6× 61 1.1× 28 0.5× 15 318
Meili Yang China 13 56 0.3× 227 1.8× 39 0.5× 30 0.5× 37 0.7× 43 535
Mohammad Shoeb United States 10 44 0.2× 293 2.3× 65 0.8× 58 1.0× 48 0.9× 12 615

Countries citing papers authored by Shigemitsu Ueyama

Since Specialization
Citations

This map shows the geographic impact of Shigemitsu Ueyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigemitsu Ueyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigemitsu Ueyama more than expected).

Fields of papers citing papers by Shigemitsu Ueyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigemitsu Ueyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigemitsu Ueyama. The network helps show where Shigemitsu Ueyama may publish in the future.

Co-authorship network of co-authors of Shigemitsu Ueyama

This figure shows the co-authorship network connecting the top 25 collaborators of Shigemitsu Ueyama. A scholar is included among the top collaborators of Shigemitsu Ueyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigemitsu Ueyama. Shigemitsu Ueyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Watari, Jiro, Shigemitsu Ueyama, Toshihiko Tomita, et al.. (2016). What types of early gastric cancer are indicated for endoscopic ultrasonography staging of invasion depth?. World Journal of Gastrointestinal Endoscopy. 8(16). 558–558. 17 indexed citations
2.
Yamauchi, Takeshi, et al.. (2014). Successful long-lasting treatment with double-filtration plasmapheresis in a case of type 2 diabetes with anti-insulin antibodies. Nihon Toseki Igakkai Zasshi. 47(2). 159–165. 1 indexed citations
3.
Makita, T., Shigemitsu Ueyama, Makoto Nagata, et al.. (2013). In-system diagnosis of RF ICs for tolerance against on-chip in-band interferers. 1–9. 18 indexed citations
4.
Takahashi, Motoko, Satoshi Miyata, Junichi Fujii, et al.. (2012). In vivo role of aldehyde reductase. Biochimica et Biophysica Acta (BBA) - General Subjects. 1820(11). 1787–1796. 39 indexed citations
5.
Fujisawa, Takashi, Masafumi Takata, Shigemitsu Ueyama, et al.. (2011). Intra-abdominal plexiform neurofibromatosis including periportal, mesentery, and gastrointestinal tract involvement in neurofibromatosis type 1: case report and review of the literature. Clinical Journal of Gastroenterology. 4(5). 292–297. 6 indexed citations
6.
Okimura, Akira, Hiroshi Hirano, Takashi Nishigami, et al.. (2009). Immunohistochemical analyses of E-cadherin, β-catenin, CD44s, and CD44v6 expressions, and Ki-67 labeling index in intraductal papillary mucinous neoplasms of the pancreas and associated invasive carcinomas. Medical Molecular Morphology. 42(4). 222–229. 10 indexed citations
7.
Hirano, Hiroshi, Keiichi Morita, Akira Okimura, et al.. (2008). Undifferentiated carcinoma with osteoclast‐like giant cells arising in a mucinous cystic neoplasm of the pancreas. Pathology International. 58(6). 383–389. 27 indexed citations
8.
Hamada, Yasuhiro, Satoshi Miyata, Tomoko Nii‐Kono, et al.. (2007). Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrology Dialysis Transplantation. 22(6). 1547–1557. 38 indexed citations
9.
Fujisawa, Takashi, Wataru Sano, Shigemitsu Ueyama, et al.. (2007). [Complete histological response in gastric cancer stage IV after neoadjuvant chemotherapy including S-1 combined with CDDP--report of a case].. PubMed. 34(13). 2297–300. 2 indexed citations
10.
Miyata, Satoshi, et al.. (2005). Methylglyoxal Induces Apoptosis through Oxidative Stress‐Mediated Activation of p38 Mitogen‐Activated Protein Kinase in Rat Schwann Cells. Annals of the New York Academy of Sciences. 1043(1). 151–157. 58 indexed citations
11.
Kuroda, Shoji, et al.. (2005). Fulminant Massive Gas Gangrene Caused by Clostridium perfringens. Internal Medicine. 44(5). 499–502. 27 indexed citations
12.
Miyata, Satoshi, Hiroyuki Miyazaki, Yushi Hirota, et al.. (2004). Methylglyoxal induces apoptosis through activation of p38 MAPK in rat Schwann cells. Biochemical and Biophysical Research Communications. 320(3). 689–695. 86 indexed citations
13.
Liu, Bing-Fen, Satoshi Miyata, Yushi Hirota, et al.. (2003). Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney International. 63(3). 947–957. 111 indexed citations
14.
Miyata, Satoshi, Hiroyuki Miyazaki, Bing-Fen Liu, et al.. (2002). Activation of MAP kinase superfamily signaling pathways by methylglyoxal. International Congress Series. 1245. 87–89. 4 indexed citations
15.
Liu, Bing-Fen, Satoshi Miyata, Hiroyuki Miyazaki, et al.. (2002). Methylglyoxal induces apoptosis in rat mesangial cells. International Congress Series. 1245. 83–85. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026